{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T05:40:36Z","timestamp":1689486036858},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000405","name":"Kids Kidney Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004185","name":"The Northern Counties Kidney Research Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004185","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.molimm.2014.07.017","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T14:32:07Z","timestamp":1408631527000},"page":"287-296","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)"],"prefix":"10.1016","volume":"63","author":[{"given":"Rachael","family":"Watson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Wearmouth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy-Claire","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Bertram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Bennaceur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona E.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel Y.","family":"Pappworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Lea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy H.J.","family":"Goodship","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Marchbank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2014.07.017_bib0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0010","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.4049\/jimmunol.180.9.5816","article-title":"Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model","volume":"180","author":"Chackerian","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0015","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1073\/pnas.74.9.3980","article-title":"Heterogeneity of nephritic factor and its identification as an immunoglobulin","volume":"74","author":"Davis","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2014.07.017_bib0020","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1167\/iovs.09-5124","article-title":"Complement factor h autoantibodies and age-related macular degeneration","volume":"51","author":"Dhillon","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.molimm.2014.07.017_bib0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.molimm.2013.05.009","article-title":"Autoantibodies against complement components and functional consequences","volume":"56","author":"Dragon-Durey","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0030","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddi066","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32","volume":"14","author":"Esparza-Gordillo","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molimm.2014.07.017_bib0040","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1073\/pnas.76.11.5867","article-title":"Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane","volume":"76","author":"Fearon","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2014.07.017_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1084\/jem.152.1.20","article-title":"Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte","volume":"152","author":"Fearon","year":"1980","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2014.07.017_bib0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.iy.13.040195.001015","article-title":"The CD19\/CR2\/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity","volume":"13","author":"Fearon","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0055","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fremeaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2014.07.017_bib0060","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ni1256","article-title":"Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling","volume":"6","author":"Gauld","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0065","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/334676a0","article-title":"Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice","volume":"334","author":"Goodnow","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2014.07.017_bib0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molimm.2012.05.009","article-title":"Factor H autoantibodies in membranoproliferative glomerulonephritis","volume":"52","author":"Goodship","year":"2012","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0075","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"Jozsi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2014.07.017_bib0080","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood-2007-02-071472","article-title":"Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome","volume":"110","author":"Jozsi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2014.07.017_bib0085","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.molimm.2007.01.036","article-title":"The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation","volume":"44","author":"Kavanagh","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0090","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s00467-010-1555-5","article-title":"Genetics and complement in atypical HUS","volume":"25","author":"Kavanagh","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/asheducation-2011.1.15","article-title":"Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations","volume":"2011","author":"Kavanagh","year":"2011","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.molimm.2014.07.017_bib0100","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2215\/CJN.05750611","article-title":"Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?","volume":"7","author":"Kavanagh","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.med.59.060106.185110","article-title":"Complement regulatory genes and hemolytic uremic syndromes","volume":"59","author":"Kavanagh","year":"2008","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.molimm.2014.07.017_bib0115","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature01315","article-title":"Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype","volume":"421","author":"Kemper","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2014.07.017_bib0120","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1084\/jem.164.5.1377","article-title":"Membrane-bound C4b interacts endogenously with complement receptor CR1 of human red cells","volume":"164","author":"Kinoshita","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2014.07.017_bib0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1084\/jem.162.1.75","article-title":"Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria","volume":"162","author":"Kinoshita","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2014.07.017_bib0130","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/ndt\/gfn063","article-title":"Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome","volume":"23","author":"Kwon","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molimm.2014.07.017_bib0135","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2014.07.017_bib0140","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1600-6143.2009.02586.x","article-title":"Anti-Factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome","volume":"9","author":"Le Quintrec","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.molimm.2014.07.017_bib0145","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1084\/jem.160.5.1558","article-title":"Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes","volume":"160","author":"Medof","year":"1984","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2014.07.017_bib0150","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1084\/jem.159.6.1669","article-title":"Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1","volume":"159","author":"Medof","year":"1984","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2014.07.017_bib0155","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1084\/jem.165.3.848","article-title":"Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids","volume":"165","author":"Medof","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2014.07.017_bib0160","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00281-014-0416-x","article-title":"Hemolytic uremic syndrome","volume":"36","author":"Mele","year":"2014","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0165","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2014.07.017_bib0170","series-title":"Complement Regulatory Proteins","author":"Morgan","year":"1999"},{"key":"10.1016\/j.molimm.2014.07.017_bib0175","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1046\/j.1523-1755.1998.00130.x","article-title":"Complement regulatory proteins in glomerular diseases","volume":"54","author":"Nangaku","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.molimm.2014.07.017_bib0180","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4049\/jimmunol.129.1.184","article-title":"Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system","volume":"129","author":"Nicholson-Weller","year":"1982","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0185","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood.V65.5.1237.1237","article-title":"Surface membrane expression by human blood leukocytes and platelets of decay-accelerating factor, a regulatory protein of the complement system","volume":"65","author":"Nicholson-Weller","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2014.07.017_bib0190","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0140-6736(03)14742-3","article-title":"Familial haemolytic uraemic syndrome and an MCP mutation","volume":"362","author":"Noris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2014.07.017_bib0195","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"Pickering","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2014.07.017_bib0200","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1074-7613(00)80669-X","article-title":"A critical role for complement in maintenance of self-tolerance","volume":"9","author":"Prodeus","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2014.07.017_bib0205","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/381751a0","article-title":"Clonal selection and learning in the antibody system","volume":"381","author":"Rajewsky","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2014.07.017_bib0210","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2249.2003.02045.x","article-title":"Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients","volume":"131","author":"Sadallah","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0215","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00467-013-2558-9","article-title":"Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses","volume":"29","author":"Sana","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/humu.20268","article-title":"An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations","volume":"27","author":"Saunders","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molimm.2014.07.017_bib0225","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/bjh.12718","article-title":"How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome","volume":"164","author":"Scully","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0230","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1160\/TH08-05-0322","article-title":"Autoantibodies in haemolytic uraemic syndrome (HUS)","volume":"101","author":"Skerka","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molimm.2014.07.017_bib0235","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.164.3878.436","article-title":"Serum C\u20323 lytic system in patients with glomerulonephritis","volume":"164","author":"Spitzer","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.molimm.2014.07.017_bib0240","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.4049\/jimmunol.1300847","article-title":"Cutting edge: receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells","volume":"190","author":"van der Touw","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imbio.2013.06.004","article-title":"Standardisation of the factor H autoantibody assay","volume":"219","author":"Watson","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.molimm.2014.07.017_bib0250","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1126\/science.2371562","article-title":"Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis","volume":"249","author":"Weisman","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.molimm.2014.07.017_bib0255","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.4049\/jimmunol.138.8.2706","article-title":"Deficiency of the C3b\/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene","volume":"138","author":"Wilson","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molimm.2013.05.224","article-title":"Complement therapy in atypical haemolytic uraemic syndrome (aHUS)","volume":"56","author":"Wong","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2014.07.017_bib0265","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2215\/CJN.07900811","article-title":"Causes of alternative pathway dysregulation in dense deposit disease","volume":"7","author":"Zhang","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589014001874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589014001874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T05:09:33Z","timestamp":1689484173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589014001874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0161589014001874"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2014.07.017","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2014.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}